David A. Siegel Insmed Inc Transaction History
Two Sigma Advisers, LP
- $47 Billion
- Q3 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Insmed Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 51,300 shares of INSM stock, worth $9.91 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
51,300
Previous 17,500
193.14%
Holding current value
$9.91 Million
Previous $1.76 Million
319.48%
% of portfolio
0.02%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding INSM
# of Institutions
649Shares Held
208MCall Options Held
3.83MPut Options Held
4.26M-
Jpmorgan Chase & CO New York, NY23MShares$4.45 Billion0.22% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y920.5MShares$3.95 Billion89.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.9MShares$3.85 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$2.76 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA7.55MShares$1.46 Billion0.18% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $26.2B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...